Neurocrine Biosciences Inc. (NBIX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Neurocrine Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Neurocrine Biosciences Inc. (NBIX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $14.8B. It trades at $145.53, down 0.32% today. 25 analysts' average target of $207.28 implies +42.4% from today's price. Kronos AI's 30-day forecast is +3.6% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $207.28 |
| Low – high | $150.00 – $253.00 |
| Analysts | 25 |
| Upside to average | +42.4% |
Kronos AI 30-day forecast
| Expected close | $151.25 (+3.6%) |
| Likely range | −0.9% … +4.6% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator